Xavier Martinez / Wall Street Journal:
Pharmaceutical leaders are skeptical of claims that AI could cure most diseases within a decade; the US FDA has yet to clear any AI-designed biotech drugs — No drug designed by artificial intelligence has won FDA clearance, and pharma leaders say biology is the obstacle
